This contract expires in 170 days (Feb 28, 2027).

Browse related active opportunities

LEIDOS BIOMEDICAL RESEARCH INC - NIAID COVID-19 ACTIV3

PIID: 75N91020F00039
Signed Date: Sep 1, 2020Effective Date: Sep 2, 2020End Date: Closes in 170 days
Award $
$159.1M
Vendor
LEIDOS BIOMEDICAL RESEARCH INC
NAICS
541715
Signed Date
Sep 1, 2020

Key Details

Dollars Obligated
$159.1M
Awarding Sub-Agency
National Institutes of Health
Parent IDIQ (PIID)
75N91019D00024
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
FREDERICK, MD

Description

NIAID COVID-19 ACTIV3

Context & Analysis

On Sep 1, 2020, Department of Health and Human Services obligated $159,121,570 to LEIDOS BIOMEDICAL RESEARCH INC for niaid covid-19 activ3. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Performance is located in FREDERICK, MD. The contract is scheduled through Feb 28, 2027 — approximately 6 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.

Contractor Information

UEI: HV8BH9BPG8Y9
Location: FREDERICK, MD
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related